22.07.2013 Views

Urology & Kidney Disease News - Cleveland Clinic

Urology & Kidney Disease News - Cleveland Clinic

Urology & Kidney Disease News - Cleveland Clinic

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

28 <strong>Urology</strong> & <strong>Kidney</strong> <strong>Disease</strong> <strong>News</strong><br />

Robotic and Laparoscopic<br />

Robotic Flexible Ureteroscopy and Laser Lithotripsy for<br />

Renal Calculi: Initial <strong>Clinic</strong>al Trial<br />

*Mihir M. Desai, MD, Monish Aron, MD, Georges-Pascal<br />

Haber, MD, Mahesh Desai, MD, Jihad Kaouk, MD,<br />

*Inderbir S. Gill, MD, MCh<br />

Retrograde uretero-renoscopy is routinely used for a variety<br />

of diagnostic and therapeutic applications involving the<br />

upper urinary tract. The increasing use of flexible ureterorenoscopy<br />

for retrograde intra-renal surgery is the result of<br />

advancements in flexible ureteroscope technology,<br />

Holmium-YAG laser lithotripsy, and ureteroscope accessories<br />

such as wires, baskets, and access sheaths. Significant<br />

technologic developments with flexible ureteroscopy<br />

include better deflection, improved optics, increased durability,<br />

and miniaturization. Recently, a novel robotic<br />

catheter system (Sensei, Hansen Medical) has been<br />

developed for intra-cardiac electrophysiologic applications.<br />

This robotic catheter system may enhance the capabilities<br />

of conventional flexible uretero-renoscopy by providing a<br />

stable, easily maneuverable, and ergonomically superior<br />

platform. We modified software and catheter-guide configurations<br />

from the original system designed for cardiac<br />

applications and initially assessed the technical feasibility<br />

of performing retrograde uretero-renoscopy in the acute<br />

swine model.<br />

Subsequent to our animal study, we performed the initial<br />

clinical trial using the flexible robotic system in 18 select<br />

patients with renal calculi. The study was performed in<br />

collaboration with the Muljibhai Patel Urological Hospital<br />

in India after obtaining IRB approval from both institutions<br />

and informed consent. Inclusion criteria included renal<br />

calculi 5-15 mm in size. All procedures were unilateral and<br />

patients with co-existing ureteral calculi or obstruction,<br />

uncontrolled infection, renal insufficiency, or solitary<br />

kidney status were excluded from the study. Mean stone<br />

Key Point:<br />

The novel flexible robotic platform can be used safely and<br />

effectively for retrograde intra-renal treatment of renal calculi<br />

in select cases. Ongoing technical refinements are likely to<br />

increase the incorporation of robotic technology in diagnostic<br />

and therapeutic flexible endoscopy.<br />

size was 11.9 mm. All patients were pre-stented for approximately<br />

2 weeks. The robotic catheter system was introduced<br />

into the renal collecting system manually under fluoroscopic<br />

control over a guidewire. All intra-renal maneuvers<br />

including stone relocation and fragmentation into 1-2 mm<br />

particles were performed exclusively using remote robotic<br />

control by the surgeon sitting at the console.<br />

All procedures were technically successful without need for<br />

conversion to manual ureteroscopy. Mean operative time<br />

was 91 minutes, robot docking time was 7 minutes, and<br />

stone localization time was 9 minutes. Mean visual analog<br />

scale rating (1 worst, 10 best) of ease of stone localization<br />

was 8.3, ease of maneuvering was 8.5, and ease of fragmentation<br />

was 9.2 . Complete stone clearance was achieved in<br />

56% of patients at 2 months based on CT scan, and 89% at 3<br />

months based in IVU. One patient required secondary<br />

ureteroscopy for residual stone. Complications included<br />

pyelonephritis (2), pyrexia (1), and temporary limb paresis<br />

(1). There was negligible fluid absorption based on calculation<br />

of inflow and egress and ethanol fluid absorption.<br />

For references, please email the editor.<br />

*Mihir Desai, MD, and Inderbir Gill, MD, are consultants<br />

and stockholders in Hansen Medical, which manufactures<br />

Sensei. TM This article is written for educational purposes only<br />

and as a convenience.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!